Acta Pharmaceuticals closes $24 million in Seed financing to advance its Alzheimer’s disease pipeline focused on early intervention and prevention.
Amount Raised
$24 Million
Round Type
Seed
BostonBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Acta Pharmaceuticals has successfully closed a $24 million Seed financing round. The funding will support their Alzheimer’s disease pipeline, specifically targeting early intervention and prevention strategies. Additionally, the company will commence a phase 1 study for GSM-779690T. This financing marks a significant step in Acta's ongoing research efforts.
Quick answer
Acta Pharmaceuticals raised $24 Million in a Seed round, dated October 15, 2026. Acta Pharmaceuticals is based in Boston, Massachusetts, United States.
- How much did Acta Pharmaceuticals raise?
- Acta Pharmaceuticals raised $24 Million in a Seed round on October 15, 2026.
- What does Acta Pharmaceuticals do?
- Acta Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for Alzheimer's disease.
- Where is Acta Pharmaceuticals based and how big is it?
- Acta Pharmaceuticals is based in Boston, Massachusetts, United States. Fundz records about 3 employees.
- Who are the decision-makers at Acta Pharmaceuticals?
- Fundz holds 1 contact at Acta Pharmaceuticals, including the Office Manager. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Acta Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
- Disc raised $422M (Post-IPO Equity) on October 20, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
- Ensho Therapeutics raised $7.3M on October 2, 2026.
- Breye Therapeutics raised $77M (Series A) on September 29, 2026.
- Orvida Pharma raised an undisclosed amount on September 15, 2026.
Who to call at Acta Pharmaceuticals, and when
A new round usually means Acta Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Acta Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Acta Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Acta Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Acta Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Acta Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.